NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

Management's predictions come from initial trial design assumptions. With 2:1 enrollment and 13.5 months median PFS for tx and 7 months median PFS for pl group, and our enrollment ramp, the trial should conclude ______. If either of those assumptions are wrong their primary completion date estimate will be wrong, but it won't stop them from giving it.